Status:
COMPLETED
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Lead Sponsor:
Stony Brook University
Conditions:
Post-operative Nausea and Vomiting
Laparoscopic Sleeve Gastrectomy
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Bariatric surgery remains the most effective therapy for obesity. Postoperative nausea and vomiting (PONV) are commonly reported following bariatric surgery. The proposed study focuses on the most com...
Detailed Description
To test this hypothesis, participants undergoing sleeve gastrectomy will be randomized to two groups: control vs Nausea specific-intervention group. All subjects will be assessed with a nausea specifi...
Eligibility Criteria
Inclusion
- Adult patients (18 years and older) undergoing LSG
Exclusion
- Allergy to medications delineated in the protocol (muscle blockade, anesthetics, reversal agents)
- Inability to provide informed consent
- History of chronic nausea and emesis requiring medication
- Poorly controlled diabetes (HgA1c\>9 mg/dl),
- History of previous bariatric or gastro-esophageal surgery
Key Trial Info
Start Date :
August 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT03435003
Start Date
August 28 2017
End Date
April 1 2019
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook University Hospital
Stony Brook, New York, United States, 11794-8191